AG
ANAB icon

Aperio Group’s AnaptysBio ANAB Stock Holding History

Aperio Group’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$644K Buy
29,974
+640
+2% +$15.5K ﹤0.01% 1843
2020
Q3 		$433K Buy
29,334
+12,913
+79% +$233K ﹤0.01% 1888
2020
Q2 		$367K Sell
16,421
-2,689
-14% -$49.2K ﹤0.01% 1929
2020
Q1 		$270K Buy
19,110
+3,261
+21% +$49.5K ﹤0.01% 1968
2019
Q4 		$258K Buy
+15,849
New +$375K ﹤0.01% 2113
2019
Q3 		– Sell
-800
Closed -$45K – 2320
2019
Q2 		$45K Buy
+800
New +$57.6K ﹤0.01% 2554

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Aperio Group's ANAB Position: Q4 2020 in Review

Aperio Group increased its AnaptysBio (ANAB) stake by 2.2% in Q4 2020, buying an estimated $15.5K and bringing the position to 29,974 shares worth $644K. The position accounts for ﹤0.01% of the portfolio, ranked #1843.

Aperio Group first reported a position in ANAB in Q2 2019 and has held it in 6 quarters since. 136 funds tracked by Wall St. Rank hold ANAB as of Q4 2020.

  • Aperio Group held 29,974 shares of AnaptysBio worth $644K as of Q4 2020.
  • Aperio Group bought 640 AnaptysBio shares in Q4 2020, an estimated $15.5K.
  • AnaptysBio made up ﹤0.01% of Aperio Group's portfolio in Q4 2020, its #1843 holding.
  • Aperio Group first reported a position in AnaptysBio in Q2 2019 and has held it in 6 quarters since.
  • 136 funds tracked by Wall St. Rank held AnaptysBio as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.